# SEAGEN INC. – FDA Inspection, May 13, 2025

Source: https://www.keypedia.com/records/fda_inspections/seagen-inc/33d5bc76-b106-486b-aa5a-2ab3314b6690
Source feed: FDA_Inspections

> FDA inspection 1272265 of SEAGEN INC., May 13, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1272265
- Company Name: SEAGEN INC.
- Inspection Date: 2025-05-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Seattle District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1253880 - 2024-11-01
- FDA Inspection 1236983 - 2024-05-02
- FDA Inspection 1119141 - 2020-01-24
- FDA Inspection 1107250 - 2019-10-04
- FDA Inspection 1040735 - 2018-01-05

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/christopher-r-czajka/42defbf3-ea06-4090-8d51-7da2b07d9e84)

Company: https://www.keypedia.com/companies/seagen-inc/07c5dcb3-661e-4212-adfc-a00316850e38

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913
